Jörg Scheidle
Director Ejecutivo en Luye Pharma (Germany) GmbH .
Cargos activos de Jörg Scheidle
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Luye Pharma AG
 Luye Pharma AG Pharmaceuticals: MajorHealth Technology Luye Pharma AG engages in the development and manufacture of pharmaceutical products. It specializes in transdermal therapeutic systems as well as biodegradable, subcutaneous implants. The company is headquartered in Miesbach, Germany. | Director/Miembro de la Junta | - | - |
Luye Pharma (Germany) GmbH
 Luye Pharma (Germany) GmbH MiscellaneousMiscellaneous Luye Pharma (Germany) GmbH engages in the acquisition, holding, management, and sale of participating interests in companies. It also provides remunerated and related services. The company was founded on April 20, 2016 and is headquartered in Miesbach, Germany. | Director Ejecutivo | - | - |
Historial de carrera de Jörg Scheidle
Antiguos cargos conocidos de Jörg Scheidle.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Director Financiero/CFO | - | - |
Formación de Jörg Scheidle.
| University of Dayton | Masters Business Admin |
Estadísticas
Internacional
| Alemania | 4 |
| Estados Unidos | 2 |
Operativa
| Director of Finance/CFO | 1 |
| Masters Business Admin | 1 |
| Director/Board Member | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
| Miscellaneous | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
Luye Pharma AG
Luye Pharma AG Pharmaceuticals: MajorHealth Technology Luye Pharma AG engages in the development and manufacture of pharmaceutical products. It specializes in transdermal therapeutic systems as well as biodegradable, subcutaneous implants. The company is headquartered in Miesbach, Germany. | Health Technology |
Luye Pharma (Germany) GmbH
Luye Pharma (Germany) GmbH MiscellaneousMiscellaneous Luye Pharma (Germany) GmbH engages in the acquisition, holding, management, and sale of participating interests in companies. It also provides remunerated and related services. The company was founded on April 20, 2016 and is headquartered in Miesbach, Germany. | Miscellaneous |
- Bolsa de valores
- Insiders
- Jörg Scheidle
- Experiencia
